One-Step In Situ Self-Assembly of Biodegradable Films for Long-Term Intravesical Bladder Cancer Therapy
- 26 January 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (2) , 825-832
Abstract
Intravesical instillation therapy is increasingly recognized as one of the most common clinical treatment strategies for bladder cancer. However, the antitumor efficacy of chemotherapy drugs is still limited due to their rapid clearance by periodic urination. To circumvent this issue, a drug-loaded thin film comprising the self-assembly of tannic acid (TA) and ferric ions (Fe3+) was in situ fabricated on the bladder wall in vivo. As expected, the [email protected] film with adjustable thickness could effectively prolong the residence time of anticancer drugs in the bladder and realize sustained release of anticancer drugs. Together with the antibacterial properties, the [email protected] film enabled improved chemotherapeutic efficacy. Moreover, the [email protected] film caused no adverse effects on bladder function, demonstrating the in vivo biocompatibility. In addition, the T2 contrast effect of Fe3+ was employed to real-time monitor the disassembly of the [email protected] film and the ensuing drug release process by magnetic resonance imaging. We believe that the [email protected] drug delivery platform with enhanced retention in the bladder would be of great potential for treating various bladder diseases.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2020YFA0909000)
- Science and Technology Commission of Shanghai Municipality (19QA1405400)
- National Natural Science Foundation of China (22174161, 91959102)
This publication has 30 references indexed in Scilit:
- A Versatile Iron–Tannin‐Framework Ink Coating Strategy to Fabricate Biomass‐Derived Iron Carbide/Fe‐N‐Carbon Catalysts for Efficient Oxygen ReductionAngewandte Chemie International Edition, 2015
- Mucoadhesive polyacrylamide nanogel as a potential hydrophobic drug carrier for intravesical bladder cancer therapyEuropean Journal of Pharmaceutical Sciences, 2015
- Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and ToxicityJournal of Clinical Oncology, 2014
- Engineering Multifunctional Capsules through the Assembly of Metal–Phenolic NetworksAngewandte Chemie International Edition, 2014
- Biocompatible, Functional Spheres Based on Oxidative Coupling Assembly of Green Tea PolyphenolsJournal of the American Chemical Society, 2013
- 1,25D3 Enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer modelsCancer, 2010
- Cancer prevention by tea: animal studies, molecular mechanisms and human relevanceNature Reviews Cancer, 2009
- The management of superficial bladder cancerNature Reviews Endocrinology, 2007
- Bladder cancer with obstructive uremia: Oncologic outcome after definitive surgical managementUrology, 2005
- Tannins and Human Health: A ReviewCritical Reviews in Food Science and Nutrition, 1998